Effects of antenatal betamethasone and dexamethasone on the lung expression of vascular endothelial growth factor and alveolarization in newborn rats exposed to acute hypoxia and recovered in normoxia or hyperoxia

Neonatology

Volumn 98, Issue 4, 2010, Pages 313-320

  Remesal, Ana ^a   San Feliciano, Laura ^a   Isidoro García, María ^a   Ludeña, Dolores ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Alveolarization; Betamethasone; Dexamethasone; Vascular endothelial growth factor

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; MESSENGER RNA; SODIUM CHLORIDE; VASCULOTROPIN;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FETUS LUNG MATURITY; GENE EXPRESSION; HYPEROXIA; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ANIMALS; ANIMALS, NEWBORN; ANOXIA; BETAMETHASONE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOCORTICOIDS; HYPEROXIA; MATERNAL EXPOSURE; PREGNANCY; PULMONARY ALVEOLI; RATS; RATS, WISTAR; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 77951947581     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000281816     Document Type: Article

References (44)

1. Voelkel NF, Vandivier RW, Tuder RM: Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006; 290:L209-L221.
2. Zhao L, Wang K, Ferrara N, Vu TH: Vascular endothelial growth factor coordinates proper development oflung epithelium and vasculature. Mech Dev 2005; 122:877-886.
3. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, Archer SL: Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxiainduced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005; 112:2477-2486.
4. Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, Grover TR, Abman SH: Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol 2005; 289:L529-L535.
5. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) a nd its receptors. FASEB J 1999; 13: 9-22.
6. Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163:1723-1729.
7. Haworth SG, Hislop AA: Lung development - the effects of chronic hypoxia. Semin Neonatol 2003; 8:1-8.
8. Remesal A, Pedraz C, San FL, Ludeña D: Pulmonary expression of vascular endothelial grow t h factor (VEGF) a nd a lveola r septation in a newborn rat model exposed to acute hypoxia and recovered under conditions of air or hyperoxia. Histol Histopathol 2009; 24:325-330.
9. Roberts RJ, Weesner KM, Bucher JR: Oxygeninduced alterations in lung vascular development in the newborn rat. Pediatr Res 1983; 17:368-375.
10. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JA MA 1995; 273: 413-418.
11. Miracle X, Di Renzo GC, Stark A, Fanaroff A, Carbonell-Estrany X, Saling E: Guideline for the use of antenatal corticosteroids for fetal maturation. J Perinat Med 2008; 36: 191-19 6 .
12. Crowley P: WITHDRAWN: prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2007; 3:CD000065.
13. Lee BH, Stoll BJ, McDonald SA, Higgins RD: Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics 2006; 117:1503-1510.
14. Burri PH: Structural aspects of postnatal lung development - alveolar formation and growth. Biol Neonate 2006; 89:313-322.
15. Pedraz C, San Feliciano L, Perez P, Revestido R, Ludeña MD, Remesal A, Fernandez F: Effect of prenatal dexamethasone on lung in neonatal rats exposed to hypoxia and recovered in oxygen or air. Pediatr Res 2003; 54:582.
16. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA: Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to plateletderived growth factor. Proc Natl Acad Sci USA 1990; 87:2628-2632.
17. Blanco LN, Frank L: Development of gasexchange surface area in rat lung. The effect of alveolar shape. Am J Respir Crit Care Med 1994; 149:759-766.
18. Weibel ER, Kistler GS, Scherle WF: Practical stereological methods for morphometric cytology. J Cell Biol 1966; 30: 23-38.
19. 2 exposure. Pediatr Res 1992; 32:215-221.
20. Okajima S, Matsuda T, Cho K, Matsumoto Y, Kobayashi Y, Fujimoto S: Antenatal dexamethasone administration impairs normal postnatal lung growth in rats. Pediatr Res 2001; 49:777-781.
21. Jobe AH, Nitsos I, Pillow JJ, Polglase GR, Kallapur SG, Newnham JP: Betamethasone dose and formulation for induced lung maturation in fetal sheep. Am J Obstet Gynecol 2009; 201:611-617.
22. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M: Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998; 341: 309-315.
23. Tanabe K, Tokuda H, Takai S, Matsushima-Nishiwaki R, Hanai Y, Hirade K, Katagiri Y, Dohi S, Kozawa O: Modulation by the steroid/thyroid hormone superfamily of TGF-betastimulated VEGF release from vascular smoot h muscle cells. J Cell Biochem 2006; 99: 187-195.
24. Hewitt DP, Mark PJ, Waddell BJ: Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology 2006; 147:5568-5574.
25. Vento G, Matassa PG, Ameglio F, Capoluongo E, Tortorolo L, Romagnoli C: Effects of early dexamethasone therapy on pulmonary fibrogenic mediators and respiratory mechanics in preterm infants. Eur Cytokine Net w 20 02; 13: 207-214.
26. Lassus P, Ristimaki A, Ylikorkala O, Viinikka L, Andersson S: Vascular endothelial growth factor in human preterm lung. Am J Respir Crit Care Med 1999; 159:1429-1433.
27. Bhatt AJ, Amin SB, Chess PR, Watkins RH, Maniscalco WM: Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoidtreated mouse lung. Pediatr Res 2000; 47: 606-613.
28. Acarregui MJ, Penisten ST, Goss KL, Ramirez K, Snyder JM: Vascular endothelial growth factor gene expression in human fetal lung in vitro. Am J Respir Cell Mol Biol 1999; 20:14-23.
29. Massaro D, Massaro GD: Dexamethasone accelerates postnatal alveolar wall thinning and alters wall composition. Am J Physiol 1986; 251:R218-R224.
30. Maniscalco WM, Watkins RH, D'Angio CT, Ryan RM: Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 1997; 16:557-567.
31. Hosford GE, Olson DM: Effects of hyperoxia on VEGF, its receptors, and HIF-2alpha in the newborn rat lung. Am J Physiol Lung Cell Mol Physiol 2003; 285:L161-L168.
32. Kovar J, Sly PD, Willet KE: Postnatal alveolar development of the rabbit. J Appl Physiol 2002; 93: 629-635.
33. Saugstad OD: Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res 1988; 23: 143-150.
34. Ekekezie II, Thibeault DW, Rezaiekhaligh MH, Norberg M, Mabry S, Zhang X, Truog WE: Endostatin and vascular endothelial cell g row t h factor (VEGF) in piglet lungs: effect of inhaled nitric oxide and hyperoxia. Pediatr Res 2003; 53: 440-446.
35. Lin YJ, Markham NE, Balasubramaniam V, Tang JR, Maxey A, Kinsella JP, Abman SH: Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 2005; 58: 22-29.
36. Veness-Meehan KA, Bottone FG Jr, Stiles AD: Effects of retinoic acid on airspace development and lung collagen in hyperoxiaexposed newborn rats. Pediatr Res 2000; 48: 434-444.
37. Roubliova XI, Van der Biest AM, Vaast P, Lu H, Jani JC, Lewi PJ, Verbeken EK, Tibboel D, Deprest JA: Effect of maternal administration of betamethasone on peripheral arterial development in fetal rabbit lungs. Neonatolog y 2008; 93: 64-72.
38. Rayburn WF, Christensen HD, Gonzalez CL: A placebocontrolled comparison between betamethasone and dexamethasone for fetal maturation: differences in neurobehavioral development of mice offspring. Am J Obstet Gynecol 1997; 176 : 842-850.
39. Buttgereit F, Brand MD, Burmester GR: Equivalent doses and relative drug potencies for nongenomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol 1999; 58: 363-368.
40. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, Huon C, Lepercq J, Dehan M, Lacaze-Masmonteil T: Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999; 341: 1190-1196.
41. Figueras-Aloy J, Serrano MM, Rodriguez JP, Perez CF, Serradilla VR, Jimenez JQ, Gonzalez RJ: Antenatal glucocorticoid treatment decreases mortality and chronic lung disease in survivors among 23- to 28-week gestational age preterm infants. Am J Perinatol 2005; 22: 441-448.
42. Feldman DM, Carbone J, Belden L, Borgida AF, Herson V: Betamethasone vs dexamethasone for the prevention of morbidity in verylowbirthweight neonates. Am J Obstet Gynecol 2007; 197: 284.
43. Thickett DR, Armstrong L, Millar AB: A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Ca re Med 2002; 16 6 : 1332-1337.
44. Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, Abman SH: Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007; 292:L1073-L1084.